Family Medicine · Riverside, CA
NPI
1124001045
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6405 Day St
Riverside, CA, 92507
Phone (951) 697-5490
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
385 services
Medicare patients, 2024
106
Average age 73
Drug cost, 2024
$1.0M
14,000 prescriptions
Company payments, 2025
$81.05
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ruben Muradyan was code 99213 (office e&m - established), 133 times for 67 patients. In total Ruben Muradyan billed 385 services in 16 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-12-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 133 | 67 | $65.19 | $8,671 |
| 99214 Office E&M - Established | Office | 71 | 50 | $75.12 | $5,334 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 27 | 27 | $133.53 | $3,605 |
| 99212 Office E&M - Established | Office | 26 | 22 | $32.54 | $846 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 26 | 26 | $19.79 | $514 |
By year: 2022 $20K for 311 services; 2023 $22K for 403 services; 2024 $23K for 385 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ruben Muradyan prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,605 prescriptions and refills. In total Ruben Muradyan wrote 14,000 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,605 | 4,480 | 486 | $22K |
| Metformin Hcl Generic | 710 | 1,994 | 222 | $7,179 |
| Amlodipine Besylate Generic | 700 | 1,913 | 205 | $4,239 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 504 | 1,378 | 145 | $5,246 |
| Losartan Potassium Generic | 469 | 1,304 | 145 | $5,677 |
| Levothyroxine Sodium Generic | 467 | 1,151 | 117 | $6,546 |
| Omeprazole Generic | 425 | 980 | 124 | $4,406 |
| Lisinopril Generic | 413 | 1,167 | 129 | $3,551 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 367 | 965 | 109 | $5,844 |
| Pioglitazone Hcl Generic | 281 | 721 | 89 | $4,519 |
| Gabapentin Generic | 275 | 504 | 83 | $4,383 |
| Hydrochlorothiazide Generic | 255 | 711 | 78 | $1,625 |
| Tamsulosin Hcl Generic | 230 | 664 | 82 | $4,583 |
| Metoprolol Succinate Generic | 213 | 556 | 63 | $3,688 |
| Furosemide Generic | 212 | 512 | 65 | $1,280 |
Brand drugs: 1,377 claims; generic drugs: 12,434 claims; opioid claims: 181.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ruben Muradyan $81.05 ($81.05 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbott Laboratories with $31.67.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.